<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T04:18:27Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:7984397" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:7984397</identifier>
        <datestamp>2021-03-25</datestamp>
        <setSpec>blackwellopen</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">BJU Int</journal-id>
              <journal-id journal-id-type="iso-abbrev">BJU Int</journal-id>
              <journal-id journal-id-type="doi">10.1111/(ISSN)1464-410X</journal-id>
              <journal-id journal-id-type="publisher-id">BJU</journal-id>
              <journal-title-group>
                <journal-title>Bju International</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">1464-4096</issn>
              <issn pub-type="epub">1464-410X</issn>
              <publisher>
                <publisher-name>John Wiley and Sons Inc.</publisher-name>
                <publisher-loc>Hoboken</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC7984397</article-id>
              <article-id pub-id-type="pmcid">PMC7984397</article-id>
              <article-id pub-id-type="pmc-uid">7984397</article-id>
              <article-id pub-id-type="pmid">32916021</article-id>
              <article-id pub-id-type="pmid">32916021</article-id>
              <article-id pub-id-type="doi">10.1111/bju.15238</article-id>
              <article-id pub-id-type="publisher-id">BJU15238</article-id>
              <article-categories>
                <subj-group subj-group-type="overline">
                  <subject>Original Article</subject>
                </subj-group>
                <subj-group subj-group-type="heading">
                  <subject>Original Articles</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Surgeon heterogeneity significantly affects functional and oncological outcomes after radical prostatectomy in the Swedish LAPPRO trial</article-title>
                <alt-title alt-title-type="right-running-head">Surgeon heterogeneity in LAPPRO</alt-title>
                <alt-title alt-title-type="left-running-head">Nyberg <italic>et al</italic>.</alt-title>
              </title-group>
              <contrib-group>
                <contrib id="bju15238-cr-0001" contrib-type="author">
                  <name>
                    <surname>Nyberg</surname>
                    <given-names>Martin</given-names>
                  </name>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-6487-1601</contrib-id>
                  <xref ref-type="aff" rid="bju15238-aff-0001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="bju15238-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="bju15238-cr-0002" contrib-type="author">
                  <name>
                    <surname>Sjoberg</surname>
                    <given-names>Daniel D.</given-names>
                  </name>
                  <xref ref-type="aff" rid="bju15238-aff-0003">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib id="bju15238-cr-0003" contrib-type="author">
                  <name>
                    <surname>Carlsson</surname>
                    <given-names>Sigrid V.</given-names>
                  </name>
                  <xref ref-type="aff" rid="bju15238-aff-0003">
                    <sup>3</sup>
                  </xref>
                  <xref ref-type="aff" rid="bju15238-aff-0004">
                    <sup>4</sup>
                  </xref>
                  <xref ref-type="aff" rid="bju15238-aff-0005">
                    <sup>5</sup>
                  </xref>
                </contrib>
                <contrib id="bju15238-cr-0004" contrib-type="author">
                  <name>
                    <surname>Wilderäng</surname>
                    <given-names>Ulrica</given-names>
                  </name>
                  <xref ref-type="aff" rid="bju15238-aff-0006">
                    <sup>6</sup>
                  </xref>
                </contrib>
                <contrib id="bju15238-cr-0005" contrib-type="author">
                  <name>
                    <surname>Carlsson</surname>
                    <given-names>Stefan</given-names>
                  </name>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-8489-5029</contrib-id>
                  <xref ref-type="aff" rid="bju15238-aff-0007">
                    <sup>7</sup>
                  </xref>
                </contrib>
                <contrib id="bju15238-cr-0006" contrib-type="author">
                  <name>
                    <surname>Stranne</surname>
                    <given-names>Johan</given-names>
                  </name>
                  <xref ref-type="aff" rid="bju15238-aff-0005">
                    <sup>5</sup>
                  </xref>
                  <xref ref-type="aff" rid="bju15238-aff-0008">
                    <sup>8</sup>
                  </xref>
                </contrib>
                <contrib id="bju15238-cr-0007" contrib-type="author">
                  <name>
                    <surname>Wiklund</surname>
                    <given-names>Peter</given-names>
                  </name>
                  <xref ref-type="aff" rid="bju15238-aff-0009">
                    <sup>9</sup>
                  </xref>
                  <xref ref-type="aff" rid="bju15238-aff-0010">
                    <sup>10</sup>
                  </xref>
                </contrib>
                <contrib id="bju15238-cr-0008" contrib-type="author">
                  <name>
                    <surname>Steineck</surname>
                    <given-names>Gunnar</given-names>
                  </name>
                  <xref ref-type="aff" rid="bju15238-aff-0006">
                    <sup>6</sup>
                  </xref>
                </contrib>
                <contrib id="bju15238-cr-0009" contrib-type="author">
                  <name>
                    <surname>Haglind</surname>
                    <given-names>Eva</given-names>
                  </name>
                  <xref ref-type="aff" rid="bju15238-aff-0011">
                    <sup>11</sup>
                  </xref>
                  <xref ref-type="aff" rid="bju15238-aff-0012">
                    <sup>12</sup>
                  </xref>
                </contrib>
                <contrib id="bju15238-cr-0010" contrib-type="author">
                  <name>
                    <surname>Hugosson</surname>
                    <given-names>Jonas</given-names>
                  </name>
                  <xref ref-type="aff" rid="bju15238-aff-0005">
                    <sup>5</sup>
                  </xref>
                  <xref ref-type="aff" rid="bju15238-aff-0008">
                    <sup>8</sup>
                  </xref>
                </contrib>
                <contrib id="bju15238-cr-0011" contrib-type="author" corresp="yes">
                  <name>
                    <surname>Bjartell</surname>
                    <given-names>Anders</given-names>
                  </name>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-5761-3786</contrib-id>
                  <xref ref-type="aff" rid="bju15238-aff-0001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="bju15238-aff-0002">
                    <sup>2</sup>
                  </xref>
                  <address>
                    <email>anders.bjartell@med.lu.se</email>
                  </address>
                </contrib>
              </contrib-group>
              <aff id="bju15238-aff-0001">
                <label>
                  <sup>1</sup>
                </label>
                <named-content content-type="organisation-division">Department of Urology</named-content>
                <institution>Skåne University Hospital</institution>
                <city>Malmö</city>
                <country country="SE">Sweden</country>
              </aff>
              <aff id="bju15238-aff-0002">
                <label>
                  <sup>2</sup>
                </label>
                <named-content content-type="organisation-division">Division of Urological Cancers</named-content>
                <named-content content-type="organisation-division">Department of Translational Medicine</named-content>
                <named-content content-type="organisation-division">Faculty of Medicine</named-content>
                <institution>Lund University</institution>
                <city>Lund</city>
                <country country="SE">Sweden</country>
              </aff>
              <aff id="bju15238-aff-0003">
                <label>
                  <sup>3</sup>
                </label>
                <named-content content-type="organisation-division">Department of Epidemiology and Biostatistics</named-content>
                <institution>Memorial Sloan Kettering Cancer Center</institution>
                <city>New York</city>
                <named-content content-type="country-part">NY</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="bju15238-aff-0004">
                <label>
                  <sup>4</sup>
                </label>
                <named-content content-type="organisation-division">Department of Surgery (Urology Service)</named-content>
                <institution>Memorial Sloan Kettering Cancer Center</institution>
                <city>New York</city>
                <named-content content-type="country-part">NY</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="bju15238-aff-0005">
                <label>
                  <sup>5</sup>
                </label>
                <named-content content-type="organisation-division">Department of Urology</named-content>
                <named-content content-type="organisation-division">Institute of Clinical Sciences</named-content>
                <institution>Sahlgrenska Academy at the University of Gothenburg</institution>
                <city>Gothenburg</city>
                <country country="SE">Sweden</country>
              </aff>
              <aff id="bju15238-aff-0006">
                <label>
                  <sup>6</sup>
                </label>
                <named-content content-type="organisation-division">Department of Oncology</named-content>
                <institution>Sahlgrenska Academy at the University of Gothenburg</institution>
                <city>Gothenburg</city>
                <country country="SE">Sweden</country>
              </aff>
              <aff id="bju15238-aff-0007">
                <label>
                  <sup>7</sup>
                </label>
                <named-content content-type="organisation-division">Department of Molecular Medicine and Surgery</named-content>
                <named-content content-type="organisation-division">Section of Urology</named-content>
                <institution>Karolinska Institute</institution>
                <city>Stockholm</city>
                <country country="SE">Sweden</country>
              </aff>
              <aff id="bju15238-aff-0008">
                <label>
                  <sup>8</sup>
                </label>
                <named-content content-type="organisation-division">Department of Urology</named-content>
                <institution>Sahlgrenska University Hospital</institution>
                <city>Gothenburg</city>
                <country country="SE">Sweden</country>
              </aff>
              <aff id="bju15238-aff-0009">
                <label>
                  <sup>9</sup>
                </label>
                <institution>Icahn School of Medicine at Mount Sinai Health System</institution>
                <city>New York</city>
                <named-content content-type="country-part">NY</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="bju15238-aff-0010">
                <label>
                  <sup>10</sup>
                </label>
                <named-content content-type="organisation-division">Department of Molecular Medicine and Surgery Section of Urology</named-content>
                <institution>Karolinska Institute</institution>
                <city>Stockholm</city>
                <country country="SE">Sweden</country>
              </aff>
              <aff id="bju15238-aff-0011">
                <label>
                  <sup>11</sup>
                </label>
                <named-content content-type="organisation-division">Department of Surgery</named-content>
                <named-content content-type="organisation-division">Institute of Clinical Sciences</named-content>
                <named-content content-type="organisation-division">Scandinavian Surgical Outcomes Research Group</named-content>
                <institution>Sahlgrenska Academy</institution>
                <institution>University of Gothenburg</institution>
                <city>Gothenburg</city>
                <country country="SE">Sweden</country>
              </aff>
              <aff id="bju15238-aff-0012">
                <label>
                  <sup>12</sup>
                </label>
                <named-content content-type="organisation-division">Department of Surgery</named-content>
                <institution>Region Västra Götaland</institution>
                <institution>Sahlgrenska University Hospital/Östra</institution>
                <city>Gothenburg</city>
                <country country="SE">Sweden</country>
              </aff>
              <author-notes>
                <corresp id="correspondenceTo"><label>*</label>
Correspondence: Anders Bjartell, Department of Urology, Skåne University Hospital, Jan Waldenströms gata 5, SE 205 02 Malmö, Sweden.<break/>
e‐mail: <email>anders.bjartell@med.lu.se</email><break/></corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>29</day>
                <month>9</month>
                <year>2020</year>
              </pub-date>
              <pub-date pub-type="ppub">
                <month>3</month>
                <year>2021</year>
              </pub-date>
              <volume>127</volume>
              <issue>3</issue>
              <issue-id pub-id-type="doi">10.1111/bju.v127.3</issue-id>
              <fpage>361</fpage>
              <lpage>368</lpage>
              <permissions>
                <!--<copyright-statement content-type="issue-copyright"> BJUI  &#x000a9; 2021 BJU International<copyright-statement>-->
                <copyright-statement content-type="article-copyright">© 2020 The Authors BJU International published by John Wiley &amp; Sons Ltd on behalf of BJU International</copyright-statement>
                <license license-type="creativeCommonsBy-nc-nd">
                  <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="file:BJU-127-361.pdf"/>
              <abstract id="bju15238-abs-0001">
                <sec id="bju15238-sec-0001">
                  <title>Objectives</title>
                  <p>To evaluate how surgeon heterogeneity – the variation in outcomes between individual surgeons – influences functional and oncological outcomes after robot‐assisted laparoscopic prostatectomy (RALP) and retropubic radical prostatectomy (RRP), and to assess whether surgeon heterogeneity affects the comparison between RALP and RRP.</p>
                </sec>
                <sec id="bju15238-sec-0002">
                  <title>Patients and Methods</title>
                  <p>Laparoscopic Prostatectomy Robot Open (LAPPRO) is a prospective, controlled, non‐randomized trial performed at 14 Swedish centres with 68 operating surgeons. A total of 4003 men with localized prostate cancer were enrolled between 2008 and 2011. The endpoints were urinary incontinence, erectile dysfunction (ED) and recurrence at 24 months after surgery. Logistic regression models were built to evaluate surgeon heterogeneity and, secondarily, surgeon‐specific factors were added to the models to investigate their influence on heterogeneity and the comparison between RALP and RRP.</p>
                </sec>
                <sec id="bju15238-sec-0003">
                  <title>Results</title>
                  <p>Among surgeons who performed at least 20 surgeries during the study period (n=25), we observed statistically significant heterogeneity for incontinence (<italic>P</italic> = 0.001), ED (<italic>P</italic> &lt; 0.001) and rate of recurrent disease (<italic>P</italic> &lt; 0.001). The significant heterogeneity remained when analysing only experienced surgeons with a stated experience of at least 250 radical prostatectomies (n=12). Among all participating surgeons (n=68), differences in surgeon volume explained 42% of the observed heterogeneity for incontinence (<italic>P</italic> = 0.003), 11% for ED (<italic>P</italic> = 0.03) and 19% for recurrence (<italic>P</italic> = 0.01). Taking surgeon volume into account when comparing RALP and RRP had a significant impact on the results. The effect was greatest for functional outcomes, and the additional adjustments for the surgeons' previous experience changed whether the difference between techniques was statistically significant or not. The surgeons’ annual volume had the greatest effect on the recurrence rate.</p>
                </sec>
                <sec id="bju15238-sec-0004">
                  <title>Conclusions</title>
                  <p>There was a large degree of heterogeneity among surgeons regarding both functional and oncological outcomes and this had a significant impact on the results when comparing RALP and RRP. Some of the observed heterogeneity was explained by differences in surgeon volume. Efforts to decrease heterogeneity are warranted and variation among surgeons must be accounted for when conducting comparative analyses between surgical techniques.</p>
                </sec>
              </abstract>
              <kwd-group>
                <kwd id="bju15238-kwd-0001">biochemical recurrence</kwd>
                <kwd id="bju15238-kwd-0002">erectile dysfunction</kwd>
                <kwd id="bju15238-kwd-0003">prostate cancer</kwd>
                <kwd id="bju15238-kwd-0004">radical prostatectomy</kwd>
                <kwd id="bju15238-kwd-0005">surgeon heterogeneity</kwd>
                <kwd id="bju15238-kwd-0006">urinary incontinence</kwd>
              </kwd-group>
              <funding-group>
                <award-group id="funding-0001">
                  <funding-source>
                    <institution-wrap>
                      <institution>National Cancer Institute </institution>
                      <institution-id institution-id-type="open-funder-registry">10.13039/100000054</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>P30‐CA008748</award-id>
                  <award-id>P50‐CA92629</award-id>
                  <award-id>U01CA199338‐02</award-id>
                </award-group>
                <award-group id="funding-0002">
                  <funding-source>Anna and Edvin Berger Foundation</funding-source>
                </award-group>
                <award-group id="funding-0003">
                  <funding-source>Region Västra Götaland, Sahlgrenska University Hospital</funding-source>
                  <award-id>ALF 13875</award-id>
                  <award-id>ALF 146201</award-id>
                  <award-id>ALF 4307771</award-id>
                  <award-id>HTA‐VGR 3011</award-id>
                </award-group>
                <award-group id="funding-0004">
                  <funding-source>Mrs. Mary von Sydow Foundation</funding-source>
                </award-group>
                <award-group id="funding-0005">
                  <funding-source>David H. Koch prostate cancer research fund</funding-source>
                </award-group>
                <award-group id="funding-0006">
                  <funding-source>
                    <institution-wrap>
                      <institution>Region Skåne </institution>
                      <institution-id institution-id-type="open-funder-registry">10.13039/501100009780</institution-id>
                    </institution-wrap>
                  </funding-source>
                </award-group>
                <award-group id="funding-0007">
                  <funding-source>
                    <institution-wrap>
                      <institution>Sidney Kimmel Foundation </institution>
                      <institution-id institution-id-type="open-funder-registry">10.13039/100011034</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>K22‐CA234400</award-id>
                </award-group>
                <award-group id="funding-0008">
                  <funding-source>
                    <institution-wrap>
                      <institution>Lunds Universitet: ALF 42202/2018 </institution>
                      <institution-id institution-id-type="open-funder-registry">10.13039/501100003252</institution-id>
                    </institution-wrap>
                  </funding-source>
                </award-group>
                <award-group id="funding-0009">
                  <funding-source>
                    <institution-wrap>
                      <institution>Cancerfonden </institution>
                      <institution-id institution-id-type="open-funder-registry">10.13039/501100002794</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>2008/922</award-id>
                  <award-id>2010/593</award-id>
                  <award-id>2013/497</award-id>
                  <award-id>2016/362</award-id>
                </award-group>
                <award-group id="funding-0010">
                  <funding-source>
                    <institution-wrap>
                      <institution>Vetenskapsrådet </institution>
                      <institution-id institution-id-type="open-funder-registry">10.13039/501100004359</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>2015‐02483</award-id>
                  <award-id>2012‐1770</award-id>
                </award-group>
              </funding-group>
              <counts>
                <fig-count count="3"/>
                <table-count count="1"/>
                <page-count count="8"/>
                <word-count count="5299"/>
              </counts>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>source-schema-version-number</meta-name>
                  <meta-value>2.0</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>cover-date</meta-name>
                  <meta-value>March 2021</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>details-of-publishers-convertor</meta-name>
                  <meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.0.0 mode:remove_FC converted:22.03.2021</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body id="bju15238-body-0001">
            <def-list list-content="abbreviations" id="bju15238-lp-0001">
              <title>Abbreviations</title>
              <def-item>
                <term>ED</term>
                <def>
                  <p>erectile dysfunction</p>
                </def>
              </def-item>
              <def-item>
                <term>RALP</term>
                <def>
                  <p>robot‐assisted laparoscopic prostatectomy</p>
                </def>
              </def-item>
              <def-item>
                <term>RP</term>
                <def>
                  <p>radical prostatectomy</p>
                </def>
              </def-item>
              <def-item>
                <term>RRP</term>
                <def>
                  <p>retropubic radical prostatectomy</p>
                </def>
              </def-item>
            </def-list>
            <sec id="bju15238-sec-0005">
              <title>Introduction</title>
              <p>Radical prostatectomy (RP) has become one of the most common urological operations [<xref rid="bju15238-bib-0001" ref-type="ref">1</xref>]. The randomized Scandinavian Prostate Cancer Group trial (SPCG‐4) showed a reduction in prostate cancer mortality after 29 years of follow‐up, with a mean gain of 2.9 life‐years with RP compared with watchful waiting [<xref rid="bju15238-bib-0002" ref-type="ref">2</xref>]. However, RP is associated with long‐term complications such as urinary incontinence and erectile dysfunction (ED) [<xref rid="bju15238-bib-0003" ref-type="ref">3</xref>], which have a major impact on patients’ quality of life [<xref rid="bju15238-bib-0002" ref-type="ref">2</xref>, <xref rid="bju15238-bib-0004" ref-type="ref">4</xref>, <xref rid="bju15238-bib-0005" ref-type="ref">5</xref>]. During the last decades, the traditional surgical approach, retropubic radical prostatectomy (RRP) has been challenged by robot‐assisted laparoscopic prostatectomy (RALP) and today RALP is more common in many countries than RRP. The extensive use of RALP, however, is not supported by strong evidence of superior functional and oncological outcomes compared to RRP [<xref rid="bju15238-bib-0006" ref-type="ref">6</xref>, <xref rid="bju15238-bib-0007" ref-type="ref">7</xref>, <xref rid="bju15238-bib-0008" ref-type="ref">8</xref>, <xref rid="bju15238-bib-0009" ref-type="ref">9</xref>, <xref rid="bju15238-bib-0010" ref-type="ref">10</xref>, <xref rid="bju15238-bib-0011" ref-type="ref">11</xref>, <xref rid="bju15238-bib-0012" ref-type="ref">12</xref>, <xref rid="bju15238-bib-0013" ref-type="ref">13</xref>, <xref rid="bju15238-bib-0014" ref-type="ref">14</xref>]. In addition, the role of the individual surgeons’ experience and skill, in relation to incontinence, impotence and recurrence rate after surgery is poorly described. Previous studies have reported significant heterogeneity among surgeons [<xref rid="bju15238-bib-0015" ref-type="ref">15</xref>, <xref rid="bju15238-bib-0016" ref-type="ref">16</xref>, <xref rid="bju15238-bib-0017" ref-type="ref">17</xref>], but few studies have reported on underlying factors and, to our knowledge, no study has investigated the effect of surgeon heterogeneity when comparing between RALP and RRP.</p>
              <p>The Laparoscopic Prostatectomy Robot Open (LAPPRO) trial is a prospective, controlled, non‐randomized multicentre trial comparing outcomes after RALP and RRP. The primary endpoint of urinary incontinence rate was assessed at 12 and 24 months after surgery, showing no statistically significant differences between surgical methods. For ED a small and statistically significant difference in favour of RALP was observed, while no significant differences were observed for oncological outcomes [<xref rid="bju15238-bib-0006" ref-type="ref">6</xref>, <xref rid="bju15238-bib-0018" ref-type="ref">18</xref>]. Analyses were restricted to surgeons with experience of at least 100 RPs, but differences among individual surgeons such as previous experience and annual caseload were not accounted for.</p>
              <p>The aim of the present study was to describe heterogeneity among all participating surgeons in relation to functional and oncological outcomes in the LAPPRO trial, with 24 months' follow‐up. We also sought to investigate which underlying surgeon‐dependent factors were of importance, and how surgeon heterogeneity influenced the results when comparing functional and oncological outcomes between RRP and RALP.</p>
            </sec>
            <sec id="bju15238-sec-0006">
              <title>Patients and Methods</title>
              <sec id="bju15238-sec-0007">
                <title>Study Design and Participants</title>
                <p>The design of the LAPPRO trial has been reported in detail [<xref rid="bju15238-bib-0006" ref-type="ref">6</xref>, <xref rid="bju15238-bib-0019" ref-type="ref">19</xref>]. Fourteen Swedish centres, seven performing RRP and seven RALP, participated during September 2008 to November 2011. This analysis was restricted to patients with the following criteria: age &lt;75 years; clinical tumour stage ≤T3; PSA concentration at baseline &lt;20 ng/mL; and no signs of distant metastasis. The study was approved by the Regional Ethical Review Board in Göteborg (no 277‐07). The trial is registered in the Current Controlled Trials database (ISRCTN 06393679).</p>
                <p>Data were collected by patient questionnaires before surgery as well as 3, 12 and 24 months postoperatively. Clinical information from outpatient hospital visits was collected on a peri‐operative case record form and at the same intervals as mentioned above. Each surgeon’s previous experience (number of either RRPs or RALPs performed) was obtained from the peri‐operative case record form on which each surgeon stated their surgical experience in categories (0–49, 50–99, 100–150, or more than 150 procedures). Surgeons who had performed more than 150 procedures were contacted retrospectively and asked for the total number of RPs performed (RRPs or RALPs) before entering the LAPPRO trial.</p>
              </sec>
              <sec id="bju15238-sec-0008">
                <title>Outcome Measurements</title>
                <p>The endpoints were urinary incontinence, ED and recurrence at 24 months after surgery. We used the same definitions as previously published [<xref rid="bju15238-bib-0018" ref-type="ref">18</xref>]. Incontinence was defined according to the number of pads used during a typical 24‐h period and ED according to question 3 of the International Index of Erectile Function. Men who reported use of intracorporeal or intra‐urethral injections of alprostadil were considered impotent. Recurrence (combination of residual disease and biochemical recurrence) was defined as a measurable PSA level &gt;0.25 ng/mL at 3‐, 12‐ or 24‐month follow‐up, and/or postoperative treatment with radiotherapy, androgen deprivation therapy or chemotherapy. Patients with missing data on functional outcomes at 24 months who reported being potent/continent at 3 and 12 months after surgery, were considered potent/continent after 24 months.</p>
              </sec>
              <sec id="bju15238-sec-0009">
                <title>Statistical Analysis</title>
                <p>To evaluate the surgeon‐specific heterogeneity for each outcome measure, we built logistic regression models and included surgeons with at least 20 surgeries during the study period as a fixed effect. The model was used to create a forest plot and to test for surgeon heterogeneity (likelihood ratio test). For each outcome, we built a model adjusted for baseline patient and tumour characteristics to account for potential differences in the case mix of patients operated on by different surgeons. As a subgroup analyses, analyses were repeated for surgeons with experience of at least 250 RPs. We also analysed whether a correlation between the three outcomes existed using Spearman’s correlation.</p>
                <p>To quantify heterogeneity among all participating surgeons we used mixed‐effects logistic regression models including surgeon as a random intercept. The model estimated the standard deviation among the surgeons’ outcomes. A large standard deviation indicated dissimilar outcomes among surgeons. We investigated how three different surgeon‐dependent factors modified the observed surgeon heterogeneity among the three outcome variables: the degree of nerve‐sparing surgery (bilateral, unilateral or no); a surgeon’s experience according to number of RPs performed prior to the current procedure; and the annual caseload of procedures during the study. Each of these factors was added to the base models, and the change as percentage of the standard deviation was recorded. Large changes indicated the factor was related to much of the observed heterogeneity.</p>
                <p>For both functional and oncological outcomes, the base models were adjusted for the same potential confounders as in previous LAPPRO publications [<xref rid="bju15238-bib-0006" ref-type="ref">6</xref>, <xref rid="bju15238-bib-0018" ref-type="ref">18</xref>]. For urinary incontinence, the base models were adjusted for age at surgery, incontinence at baseline, body mass index (≥30 vs &lt;30 kg/m<sup>2</sup>), history of inguinal hernia, history of abdominal surgery, diabetes, history of lung disease, history of mental disease, pathology prostate weight (0–19, 20–39, 40–59, 60–79, ≥80 g), clinical T‐stage (cT1, cT2, cT3), preoperative PSA (0–4.4, 4.5–6.1, 6.2–9.1, 9.2–20 ng/mL), biopsy Gleason score (4–7 vs 8–10), and length of cancer in biopsy core (0–3.7, 3.8–7.6, 7.7–15.9, ≥16 mm). ED models were adjusted for age at surgery, baseline potency, diabetes, history of inguinal hernia, smoking (never, former, current), history of cardiovascular disease, relationship status, clinical T‐stage, preoperative PSA, biopsy Gleason score, and length of cancer in biopsy core. Models for recurrence included pathology prostate weight, pathology T‐stage (pT1, pT2, pT3), preoperative PSA level, and prostatectomy Gleason score. For the subgroup analyses of experienced surgeons we created an additional model where, in addition to adjustments for baseline patient and tumour characteristics, we also adjusted for the surgeons' annual caseload.</p>
                <p>We also undertook analyses to assess whether surgeon‐dependent factors modified our assessment of RALP vs RRP. The mixed‐effects models described above were repeated including a covariate for the type of surgery performed.</p>
                <p>All analyses were repeated excluding surgeons who performed fewer than 20 surgeries during the LAPPRO trial to assess whether any reported results were sensitive to including the lowest‐volume surgeons. All analyses were conducted using R 3.5 (R Foundation for Statistical Computing, Vienna, Austria) with the lme4 package [<xref rid="bju15238-bib-0020" ref-type="ref">20</xref>].</p>
              </sec>
            </sec>
            <sec sec-type="results" id="bju15238-sec-0010">
              <title>Results</title>
              <p>Of 4003 patients included in the LAPPRO trial, 3443 were evaluable for the present analyses, 2617 after RALP and 826 after RRP (Fig. <xref rid="bju15238-fig-0001" ref-type="fig">1</xref>). Patient and tumour characteristics are shown in Table <xref rid="bju15238-tbl-0001" ref-type="table">1</xref>. The RPs were performed by 68 surgeons. Those operating with a robot‐assisted technique were less experienced (median [interquartile range] 62 [19–132] vs 148 [99–388] procedures), but had a higher annual caseload (median [interquartile range] 41 [27–61] vs 6 [3–12] cases) than surgeons operating with the open technique. RALP procedures were more often nerve‐sparing compared with RRPs (Table <xref rid="bju15238-tbl-0001" ref-type="table">1</xref>).</p>
              <fig fig-type="Fig." xml:lang="en" id="bju15238-fig-0001" orientation="portrait" position="float">
                <label>Fig. 1</label>
                <caption>
                  <p>Enrolment. Numbers may not sum up, as the same participant may have fulfilled more than one exclusion criterion. CRF, case record form.</p>
                </caption>
                <graphic id="jats-graphic-1" xlink:href="BJU-127-361-g002"/>
              </fig>
              <table-wrap id="bju15238-tbl-0001" xml:lang="en" content-type="Table" orientation="portrait" position="float">
                <label>Table 1</label>
                <caption>
                  <p>Patient, tumour and surgeon characteristics.</p>
                </caption>
                <table frame="hsides" rules="groups">
                  <col style="border-right:solid 1px #000000" span="1"/>
                  <col style="border-right:solid 1px #000000" span="1"/>
                  <col style="border-right:solid 1px #000000" span="1"/>
                  <col style="border-right:solid 1px #000000" span="1"/>
                  <thead valign="top">
                    <tr style="border-bottom:solid 1px #000000">
                      <th align="left" valign="top" rowspan="1" colspan="1">Variable</th>
                      <th align="left" valign="top" rowspan="1" colspan="1">
                        <p>RALP</p>
                        <p><italic>N</italic> = 2617</p>
                      </th>
                      <th align="left" valign="top" rowspan="1" colspan="1">
                        <p>RRP</p>
                        <p><italic>N</italic> = 826</p>
                      </th>
                      <th align="left" valign="top" rowspan="1" colspan="1">
                        <italic>P</italic>
                      </th>
                    </tr>
                  </thead>
                  <tbody>
                    <tr>
                      <td align="left" rowspan="1" colspan="1">
                        <bold>Age at surgery, years</bold>
                      </td>
                      <td align="left" rowspan="1" colspan="1">63 (58, 67)</td>
                      <td align="left" rowspan="1" colspan="1">63 (59, 67)</td>
                      <td align="char" char="." rowspan="1" colspan="1">0.4</td>
                    </tr>
                    <tr>
                      <td align="left" rowspan="1" colspan="1">
                        <bold>Preoperative PSA, ng/mL</bold>
                      </td>
                      <td align="left" rowspan="1" colspan="1">6.0 (4.5, 8.8)</td>
                      <td align="left" rowspan="1" colspan="1">6.3 (4.5, 9.1)</td>
                      <td align="char" char="." rowspan="1" colspan="1">0.13</td>
                    </tr>
                    <tr>
                      <td align="left" colspan="4" rowspan="1">
                        <bold>Clinical T‐stage, <italic>n</italic> (%)</bold>
                      </td>
                    </tr>
                    <tr>
                      <td align="left" style="padding-left:10%" rowspan="1" colspan="1">T1</td>
                      <td align="left" rowspan="1" colspan="1">1547 (59)</td>
                      <td align="left" rowspan="1" colspan="1">547 (66)</td>
                      <td align="char" char="." rowspan="4" colspan="1">&lt;0.001</td>
                    </tr>
                    <tr>
                      <td align="left" style="padding-left:10%" rowspan="1" colspan="1">T2</td>
                      <td align="left" rowspan="1" colspan="1">994 (38)</td>
                      <td align="left" rowspan="1" colspan="1">250 (30)</td>
                    </tr>
                    <tr>
                      <td align="left" style="padding-left:10%" rowspan="1" colspan="1">T3</td>
                      <td align="left" rowspan="1" colspan="1">76 (2.9)</td>
                      <td align="left" rowspan="1" colspan="1">29 (3.5)</td>
                    </tr>
                    <tr>
                      <td align="left" style="padding-left:10%" rowspan="1" colspan="1">T4</td>
                      <td align="left" rowspan="1" colspan="1">0 (0)</td>
                      <td align="left" rowspan="1" colspan="1">0 (0)</td>
                    </tr>
                    <tr>
                      <td align="left" colspan="4" rowspan="1">
                        <bold>Biopsy Gleason score, <italic>n</italic> (%)</bold>
                      </td>
                    </tr>
                    <tr>
                      <td align="left" style="padding-left:10%" rowspan="1" colspan="1">4–7</td>
                      <td align="left" rowspan="1" colspan="1">2455 (94)</td>
                      <td align="left" rowspan="1" colspan="1">777 (94)</td>
                      <td align="char" char="." rowspan="3" colspan="1">&gt;0.9</td>
                    </tr>
                    <tr>
                      <td align="left" style="padding-left:10%" rowspan="1" colspan="1">8–10</td>
                      <td align="left" rowspan="1" colspan="1">150 (5.8)</td>
                      <td align="left" rowspan="1" colspan="1">48 (5.8)</td>
                    </tr>
                    <tr>
                      <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Unknown</td>
                      <td align="left" rowspan="1" colspan="1">12</td>
                      <td align="left" rowspan="1" colspan="1">1</td>
                    </tr>
                    <tr>
                      <td align="left" colspan="4" rowspan="1">
                        <bold>Pathological T‐stage, <italic>n</italic> (%)</bold>
                      </td>
                    </tr>
                    <tr>
                      <td align="left" style="padding-left:10%" rowspan="1" colspan="1">T1</td>
                      <td align="left" rowspan="1" colspan="1">0 (0)</td>
                      <td align="left" rowspan="1" colspan="1">0 (0)</td>
                      <td align="char" char="." rowspan="5" colspan="1">0.6</td>
                    </tr>
                    <tr>
                      <td align="left" style="padding-left:10%" rowspan="1" colspan="1">T2</td>
                      <td align="left" rowspan="1" colspan="1">1852 (72)</td>
                      <td align="left" rowspan="1" colspan="1">603 (74)</td>
                    </tr>
                    <tr>
                      <td align="left" style="padding-left:10%" rowspan="1" colspan="1">T3</td>
                      <td align="left" rowspan="1" colspan="1">696 (27)</td>
                      <td align="left" rowspan="1" colspan="1">210 (26)</td>
                    </tr>
                    <tr>
                      <td align="left" style="padding-left:10%" rowspan="1" colspan="1">T4</td>
                      <td align="left" rowspan="1" colspan="1">10 (0.4)</td>
                      <td align="left" rowspan="1" colspan="1">4 (0.5)</td>
                    </tr>
                    <tr>
                      <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Unknown</td>
                      <td align="left" rowspan="1" colspan="1">59</td>
                      <td align="left" rowspan="1" colspan="1">9</td>
                    </tr>
                    <tr>
                      <td align="left" colspan="4" rowspan="1">
                        <bold>Pathological Gleason score, <italic>n</italic> (%)</bold>
                      </td>
                    </tr>
                    <tr>
                      <td align="left" style="padding-left:10%" rowspan="1" colspan="1">4–7</td>
                      <td align="left" rowspan="1" colspan="1">2402 (93)</td>
                      <td align="left" rowspan="1" colspan="1">772 (94)</td>
                      <td align="char" char="." rowspan="3" colspan="1">0.3</td>
                    </tr>
                    <tr>
                      <td align="left" style="padding-left:10%" rowspan="1" colspan="1">8–10</td>
                      <td align="left" rowspan="1" colspan="1">179 (6.9)</td>
                      <td align="left" rowspan="1" colspan="1">47 (5.7)</td>
                    </tr>
                    <tr>
                      <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Unknown</td>
                      <td align="left" rowspan="1" colspan="1">36</td>
                      <td align="left" rowspan="1" colspan="1">7</td>
                    </tr>
                    <tr>
                      <td align="left" rowspan="1" colspan="1">
                        <bold>Path. prostate weight, g</bold>
                      </td>
                      <td align="left" rowspan="1" colspan="1">42 (34, 53)</td>
                      <td align="left" rowspan="1" colspan="1">44 (36, 54)</td>
                      <td align="char" char="." rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Unknown</td>
                      <td align="left" rowspan="1" colspan="1">32</td>
                      <td align="left" rowspan="1" colspan="1">12</td>
                      <td align="char" char="." rowspan="1" colspan="1">&lt;0.001</td>
                    </tr>
                    <tr>
                      <td align="left" colspan="4" rowspan="1">
                        <bold>Nerve‐sparing status, <italic>n</italic> (%)</bold>
                      </td>
                    </tr>
                    <tr>
                      <td align="left" style="padding-left:10%" rowspan="1" colspan="1">None</td>
                      <td align="left" rowspan="1" colspan="1">813 (31)</td>
                      <td align="left" rowspan="1" colspan="1">336 (41)</td>
                      <td align="char" char="." rowspan="4" colspan="1">&lt;0.001</td>
                    </tr>
                    <tr>
                      <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Unilateral</td>
                      <td align="left" rowspan="1" colspan="1">1012 (39)</td>
                      <td align="left" rowspan="1" colspan="1">194 (24)</td>
                    </tr>
                    <tr>
                      <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Bilateral</td>
                      <td align="left" rowspan="1" colspan="1">790 (30)</td>
                      <td align="left" rowspan="1" colspan="1">294 (36)</td>
                    </tr>
                    <tr>
                      <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Unknown</td>
                      <td align="left" rowspan="1" colspan="1">2</td>
                      <td align="left" rowspan="1" colspan="1">2</td>
                    </tr>
                    <tr>
                      <td align="left" rowspan="1" colspan="1">
                        <bold>BMI, kg/m<sup>2</sup></bold>
                      </td>
                      <td align="left" rowspan="1" colspan="1">26 (24, 28)</td>
                      <td align="left" rowspan="1" colspan="1">26 (24, 28)</td>
                      <td align="char" char="." rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Unknown</td>
                      <td align="left" rowspan="1" colspan="1">346</td>
                      <td align="left" rowspan="1" colspan="1">117</td>
                      <td align="char" char="." rowspan="1" colspan="1">0.042</td>
                    </tr>
                    <tr>
                      <td align="left" colspan="4" rowspan="1">
                        <bold>Smoking status, <italic>n</italic> (%)</bold>
                      </td>
                    </tr>
                    <tr>
                      <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Never</td>
                      <td align="left" rowspan="1" colspan="1">914 (40)</td>
                      <td align="left" rowspan="1" colspan="1">302 (42)</td>
                      <td align="char" char="." rowspan="4" colspan="1">0.3</td>
                    </tr>
                    <tr>
                      <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Former</td>
                      <td align="left" rowspan="1" colspan="1">1165 (51)</td>
                      <td align="left" rowspan="1" colspan="1">357 (50)</td>
                    </tr>
                    <tr>
                      <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Current</td>
                      <td align="left" rowspan="1" colspan="1">224 (9.7)</td>
                      <td align="left" rowspan="1" colspan="1">59 (8.2)</td>
                    </tr>
                    <tr>
                      <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Unknown</td>
                      <td align="left" rowspan="1" colspan="1">314</td>
                      <td align="left" rowspan="1" colspan="1">108</td>
                    </tr>
                    <tr>
                      <td align="left" rowspan="1" colspan="1">
                        <bold>Cardiovascular disease, <italic>n</italic> (%)</bold>
                      </td>
                      <td align="left" rowspan="1" colspan="1">800 (35)</td>
                      <td align="left" rowspan="1" colspan="1">247 (35)</td>
                      <td align="char" char="." rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Unknown</td>
                      <td align="left" rowspan="1" colspan="1">319</td>
                      <td align="left" rowspan="1" colspan="1">111</td>
                      <td align="char" char="." rowspan="1" colspan="1">&gt;0.9</td>
                    </tr>
                  </tbody>
                </table>
                <table-wrap-foot id="bju15238-ntgp-0001">
                  <fn id="bju15238-note-0001">
                    <p>BMI, body mass index; RALP, robot‐assisted laparoscopic prostatectomy; RRP, retropubic radical prostatectomy.</p>
                  </fn>
                  <fn id="bju15238-note-0002">
                    <p>Values are presented as median (interquartile range), unless otherwise indicated.</p>
                  </fn>
                </table-wrap-foot>
                <permissions>
                  <copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
                </permissions>
              </table-wrap>
              <sec id="bju15238-sec-0011">
                <title>Surgeon Heterogeneity and Outcomes</title>
                <p>Among participating surgeons with at least 20 surgeries during the study period (n=25) the incontinence rate varied from 5% to 30%, representing statistically significant heterogeneity (<italic>P</italic> = 0.001). The rate of ED varied from 61% to 93% (<italic>P</italic> &lt; 0.001) and recurrent disease from 4% to 35% (<italic>P</italic> &lt; 0.001; Fig. <xref rid="bju15238-fig-0002" ref-type="fig">2a–c</xref>).</p>
                <fig fig-type="Fig." xml:lang="en" id="bju15238-fig-0002" orientation="portrait" position="float">
                  <label>Fig. 2</label>
                  <caption>
                    <p>Surgeon heterogeneity and outcomes: (a) urinary incontinence, (b) erectile dysfunction and (c) recurrent disease. Rates (point estimates) and 95% CIs (horizontal lines) are adjusted for baseline patient and tumour characteristics (see statistical methods). Circles indicate a surgeon performing robot‐assisted laparoscopic prostatectomy (RALP) and triangles indicate a surgeon performing open retropubic radical prostatectomy (RRP). Surgeons with at least 20 surgeries during the study period are illustrated.</p>
                  </caption>
                  <graphic id="jats-graphic-3" xlink:href="BJU-127-361-g003"/>
                </fig>
                <p>For surgeons who had performed more than 250 RPs (n=12), statistically significant heterogeneity was found for rate of incontinence (<italic>P</italic> = 0.008), rate of ED (<italic>P</italic> &lt; 0.001) and recurrence rate (<italic>P</italic> = 0.03). By adding adjustment for annual caseload, statistically significant heterogeneity was found for incontinence rate (<italic>P</italic> = 0.009) and rate of ED (<italic>P</italic> &lt; 0.001), whereas heterogeneity for recurrence rate was no longer significant (<italic>P</italic> = 0.8).</p>
                <p>There were no statistically significant correlations between the outcomes (incontinence and ED, <italic>r</italic>
<sub>s</sub> = −0.001, <italic>P</italic> &gt; 0.9; incontinence and recurrence rate, <italic>r</italic>
<sub>s</sub> = −0.25, <italic>P</italic> = 0.2; ED and recurrence rate, <italic>r</italic>
<sub>s</sub> = 0.23, <italic>P</italic> = 0.3).</p>
              </sec>
              <sec id="bju15238-sec-0012">
                <title>Surgeon‐Dependent Factors</title>
                <p>The surgeons’ prior experience, annual caseload and degree of nerve‐sparing were analysed separately and in combination, and the change was recorded as a percentage of the standard deviation.</p>
                <p>Surgeons’ experience accounted for 42% of observed heterogeneity regarding incontinence (<italic>P</italic> = 0.003) and 11% regarding ED (<italic>P</italic> = 0.03), but did not significantly influence recurrence. The degree of nerve‐sparing explained 5% of heterogeneity in both incontinence and ED (<italic>P</italic> = 0.002 and <italic>P</italic> ≤0.001, respectively), but did not significantly change recurrence heterogeneity. Annual caseload did not significantly influence either incontinence or ED (nonsignificant) but accounted for 19% of heterogeneity regarding recurrence (<italic>P</italic> = 0.01).</p>
                <p>To assess whether the comparison of surgical technique was affected when the surgeons’ previous experience, annual caseload and degree of nerve‐sparing surgery were taken into account, analyses were repeated including a covariate for the type of surgery performed (Fig. <xref rid="bju15238-fig-0003" ref-type="fig">3a–c</xref>).</p>
                <fig fig-type="Fig." xml:lang="en" id="bju15238-fig-0003" orientation="portrait" position="float">
                  <label>Fig. 3</label>
                  <caption>
                    <p>Surgeon heterogeneity and difference by surgical modality. (a) urinary incontinence, (b) erectile dysfunction and (c) recurrent disease. Odds ratios (point estimates) and 95% CIs (horizontal line) are all adjusted for baseline patient and tumour characteristics (see <xref rid="bju15238-sec-0005" ref-type="sec">statistical analyses</xref>). The <italic>y</italic>‐axis indicates which additional variables were included in the logistic regression model. The <italic>x</italic>‐axis shows the odds ratio for open retropubic radical prostatectomy (RRP) vs robot‐assisted laparoscopic prostatectomy (RALP).</p>
                  </caption>
                  <graphic id="jats-graphic-5" xlink:href="BJU-127-361-g001"/>
                </fig>
                <p>In the base model, only adjusting for differences in patient and tumour characteristics, the difference between techniques in incontinence rate was statistically significantly lower after RRP than after RALP (Fig. <xref rid="bju15238-fig-0003" ref-type="fig">3a</xref>). Adjusting for annual caseload increased the difference between techniques, whereas adjustments for previous experience reduced the difference in incontinence rate to a statistically nonsignificant level.</p>
                <p>Regarding ED there was no statistically significant difference between techniques at baseline (Fig. <xref rid="bju15238-fig-0003" ref-type="fig">3b</xref>), but adjusting for previous experience of surgeons resulted in a statistically significant difference in favour of RALP. Adjustment for annual caseload or nerve‐sparing made the techniques more similar.</p>
                <p>Regarding recurrence rate, no statistically significant difference was seen between surgical techniques in the base model (Fig. <xref rid="bju15238-fig-0003" ref-type="fig">3c</xref>), and the additional adjustments did not change this.</p>
                <p>The results remained largely unchanged when analyses were repeated and surgeons who performed fewer than 20 surgeries during the study period were excluded (nonsignificant).</p>
              </sec>
            </sec>
            <sec sec-type="discussion" id="bju15238-sec-0013">
              <title>Discussion</title>
              <p>In the present study, we analysed surgeon heterogeneity from three different perspectives: (i) how it affected functional and oncological outcomes; (ii) which underlying factors connected with the surgeons were of importance; and (iii) how surgeon heterogeneity affected the comparison between RALP and RRP. We found large and statistically significant variation among individual surgeons regarding both functional and oncological outcomes. For functional outcomes the most important factor influencing heterogeneity was the surgeons' previous experience, while annual caseload had the greatest impact on the oncological outcome. Adjusting for these surgeon volume‐related factors had a statistically significant effect on the results when comparing RALP and RRP.</p>
              <p>LAPPRO is a prospective, multicentre trial comparing outcomes after RRP and RALP, including 68 operating surgeons with varying experience. To investigate surgeon heterogeneity, we analysed patients operated on by all surgeons in the LAPPRO cohort as well as a subgroup of patients operated on by experienced surgeons with a previous caseload of more than 250 RPs. The definition of experienced surgeons was based on a previous report indicating that the learning curve for open surgery plateaus at 250 RRPs [<xref rid="bju15238-bib-0021" ref-type="ref">21</xref>]. We found a considerable and statistically significant variation among individual surgeons’ case mix‐adjusted outcomes for all surgeons but also for the subgroup of experienced surgeons. For functional outcomes the most important factor influencing the observed heterogeneity was previous experience, while annual volume had the greatest impact on heterogeneity for recurrence rate.</p>
              <p>While heterogeneity in functional and oncological outcomes has been described earlier [<xref rid="bju15238-bib-0015" ref-type="ref">15</xref>, <xref rid="bju15238-bib-0016" ref-type="ref">16</xref>, <xref rid="bju15238-bib-0017" ref-type="ref">17</xref>, <xref rid="bju15238-bib-0022" ref-type="ref">22</xref>, <xref rid="bju15238-bib-0023" ref-type="ref">23</xref>, <xref rid="bju15238-bib-0024" ref-type="ref">24</xref>], underlying factors explaining such heterogeneity have not been reported in detail for RALP or RRP. In 2010, Bianco et al. [<xref rid="bju15238-bib-0017" ref-type="ref">17</xref>] described variations among experienced surgeons in cancer control after RRP in a study from four high‐volume centres. They found statistically significant heterogeneity in prostate cancer recurrence rate independent of surgeon experience. In a single‐centre study, Vickers et al. [<xref rid="bju15238-bib-0015" ref-type="ref">15</xref>] described a significant between‐surgeon variation for potency and urinary continence 1 year after RRP in 1910 patients who were treated by 11 different surgeons. A Swedish population‐based study looking at the effects of surgeon’s (<italic>n</italic> = 9) variability on oncological and functional outcomes, also reported large heterogeneity in continence rate after RRP, but not for ED or recurrence rate [<xref rid="bju15238-bib-0016" ref-type="ref">16</xref>]. In 2018, Huynh et al. [<xref rid="bju15238-bib-0024" ref-type="ref">24</xref>] showed a 10‐fold variation in 3‐month continence rate when comparing five surgeons. Surgeon volume as an important factor for outcomes after RP was first described by Begg et al. [<xref rid="bju15238-bib-0023" ref-type="ref">23</xref>] and has been commented on in follow‐up papers [<xref rid="bju15238-bib-0025" ref-type="ref">25</xref>] and in subsequent studies on learning curve [<xref rid="bju15238-bib-0021" ref-type="ref">21</xref>, <xref rid="bju15238-bib-0026" ref-type="ref">26</xref>, <xref rid="bju15238-bib-0027" ref-type="ref">27</xref>, <xref rid="bju15238-bib-0028" ref-type="ref">28</xref>, <xref rid="bju15238-bib-0029" ref-type="ref">29</xref>]. Taken together, our results support most previous findings that surgeon heterogeneity and surgeon volume significantly affect long‐term outcomes after RP. However, even though volume factors are important, most of the observed heterogeneity remained after taking these factors into account. This means that experience and high volume is no guarantee of a favourable outcome. Although not fully explored, many other factors may contribute, including paying attention to every detailed step in the procedure and the set‐up of the surgical training.</p>
              <p>Since the primary aim of LAPPRO was to assess differences in outcomes by type of surgery, we also undertook analyses to evaluate how surgeon‐dependent factors associated with surgeon heterogeneity affected the comparison between RALP and RRP. The additional adjustments for the surgeons' previous experience and annual caseload had significant effects on the comparison for all outcomes. The impact was greatest for functional outcomes and changed whether the difference between techniques was statistically significant or not.</p>
              <p>Using national register data, Hu et al. [<xref rid="bju15238-bib-0007" ref-type="ref">7</xref>] compared the effects of minimally invasive RP and RRP and reported that the adding of surgeon volume to the case mix‐adjusted base model did not affect functional outcomes, which is in contrast to our findings. Other cohort studies comparing RRP and RALP did not adjust for differences between the surgeons’ individual results [<xref rid="bju15238-bib-0006" ref-type="ref">6</xref>, <xref rid="bju15238-bib-0008" ref-type="ref">8</xref>, <xref rid="bju15238-bib-0010" ref-type="ref">10</xref>, <xref rid="bju15238-bib-0011" ref-type="ref">11</xref>, <xref rid="bju15238-bib-0012" ref-type="ref">12</xref>, <xref rid="bju15238-bib-0013" ref-type="ref">13</xref>, <xref rid="bju15238-bib-0018" ref-type="ref">18</xref>]. In the only randomized trial comparing RRP and RALP published to date, similar functional outcomes were reported, whereas there was a difference regarding recurrence in favour of RALP (3% vs 9%) at 24‐month follow‐up [<xref rid="bju15238-bib-0009" ref-type="ref">9</xref>]. However, the authors recommended caution in interpretation of the oncological outcomes because of the lack of standardization in postoperative management. Furthermore, with only one surgeon in each randomization arm, external validity was low and it was not possible to evaluate surgeon heterogeneity. Our results clearly show that surgeon volume significantly impacts long‐term outcomes after RP and that it affects the comparison between techniques. Detailed knowledge is needed, not only of the cohort, but also of the surgeons, to minimize the risk of analysing differences between surgeons rather than true differences between the surgical techniques. There is a need for additional studies to better understand how the surgeon's individual experience and skills affect the results when comparing different surgical techniques such as RALP and RRP.</p>
              <p>Efforts to decrease the wide heterogeneity in outcomes are warranted, irrespective of surgical approach, and can be facilitated by continuously reporting and monitoring surgical outcomes in quality registers. Organizing training of new surgeons, defining basic skills criteria as well as a minimum of annual cases performed by an individual surgeon, and peer‐to‐peer observation in the operating room with feedback is critical.</p>
              <p>Strengths of the present study include the large number of patients included (<italic>n</italic> = 3443), the high response rate to questionnaires [<xref rid="bju15238-bib-0006" ref-type="ref">6</xref>, <xref rid="bju15238-bib-0018" ref-type="ref">18</xref>] as well as the multicentre design and the large number of surgeons (<italic>n</italic> = 68), which is a prerequisite for the validity of outcomes and for an investigation of surgeon heterogeneity. The prospective nature of the data collection, the detailed data on surgeons’ experience as well as on peri‐operative details such as nerve‐sparing are additional strengths. The present study is unique in that we have explored the impact of different underlying factors explaining surgeon heterogeneity which have not been reported earlier in detail in a large prospective study.</p>
              <p>The study is limited by the non‐randomized design of the trial. The results represent a nationwide cohort including hospitals of different size and surgeons with different training background, which can be a potential limitation in terms of generalizability to other surgeons and settings around the world. In previous reports, we have described differences between the RALP and RRP cohorts regarding the frequency and various degrees of nerve‐sparing [<xref rid="bju15238-bib-0006" ref-type="ref">6</xref>]. We have also reported that stratification of the cohorts based on D'Amico risk groups affected outcome analyses [<xref rid="bju15238-bib-0030" ref-type="ref">30</xref>]. Such differences between the RALP and RRP groups also indicate that direct comparison between the surgical methods must be carried out with caution. Results from previous subgroup analyses are not quite comparable with the data presented here because surgeons with less experience are also included in the present analyses.</p>
              <p>In conclusion, we have demonstrated a large and statistically significant variation between individual surgeons in functional and oncological outcomes after RP. Although surgeons’ previous experience and annual caseload influenced heterogeneity significantly, a large degree of heterogeneity remained after taking these volume‐related factors into account. Importantly, adjusting for surgeon volume affected whether there was an advantage associated with RALP or RRP, which indicates that studies comparing different surgical procedures should be interpreted with caution. Strategies to decrease surgeon heterogeneity must be prioritized.</p>
            </sec>
            <sec sec-type="COI-statement" id="bju15238-sec-0015">
              <title>Conflicts of interest</title>
              <p>None declared.</p>
            </sec>
          </body>
          <back>
            <ack id="bju15238-sec-0014">
              <title>Acknowledgements</title>
              <p>This study was supported by research grants from the Swedish Cancer Society (2008/922, 2010/593, 2013/497, 2016/362), the Swedish Research Council (2012‐1770, 2015‐02483), Region Västra Götaland, Sahlgrenska University Hospital (ALFBGB grants 13875, 146201, 4307771; HTA–VGR 6011; agreement concerning research and education of doctors), the Mrs Mary von Sydow Foundation, and the Anna and Edvin Berger Foundation. Drs Martin Nyberg and Anders Bjartell were supported by research grants from Region Skåne, Sweden and Lund University (ALF 42202/2018). The work of Drs Sigrid Carlsson and Dan Sjoberg on this paper was supported in part by a Cancer Centre Support Grant from the National Cancer Institute made to Memorial Sloan Kettering Cancer Centre (P30‐CA008748). Dr Sigrid Carlsson’s work was also supported in part by funds from the Sidney Kimmel Centre for Prostate and Urologic Cancers, National Institutes of Health/National Cancer Institute Transition Career Development Award (K22‐CA234400).</p>
            </ack>
            <ref-list content-type="cited-references" id="bju15238-bibl-0001">
              <title>References</title>
              <ref id="bju15238-bib-0001">
                <label>1</label>
                <mixed-citation publication-type="journal" id="bju15238-cit-0001"><string-name><surname>Cooperberg</surname><given-names>MR</given-names></string-name>, <string-name><surname>Broering</surname><given-names>JM</given-names></string-name>, <string-name><surname>Carroll</surname><given-names>PR</given-names></string-name>. <article-title>Time trends and local variation in primary treatment of localized prostate cancer</article-title>. <source xml:lang="en">J Clin Oncol</source><year>2010</year>; <volume>28</volume>: <fpage>1117</fpage>–<lpage>23</lpage>
<pub-id pub-id-type="pmid">20124165</pub-id></mixed-citation>
              </ref>
              <ref id="bju15238-bib-0002">
                <label>2</label>
                <mixed-citation publication-type="journal" id="bju15238-cit-0002"><string-name><surname>Bill‐Axelson</surname><given-names>A</given-names></string-name>, <string-name><surname>Holmberg</surname><given-names>L</given-names></string-name>, <string-name><surname>Garmo</surname><given-names>H</given-names></string-name><bold>et al.</bold><article-title>Radical prostatectomy or watchful waiting in prostate cancer – 29‐year follow‐up</article-title>. <source xml:lang="en">N Engl J Med</source><year>2018</year>; <volume>379</volume>: <fpage>2319</fpage>–<lpage>29</lpage>
<pub-id pub-id-type="pmid">30575473</pub-id></mixed-citation>
              </ref>
              <ref id="bju15238-bib-0003">
                <label>3</label>
                <mixed-citation publication-type="journal" id="bju15238-cit-0003"><string-name><surname>Bianco</surname><given-names>FJ</given-names><suffix>Jr</suffix></string-name>, <string-name><surname>Scardino</surname><given-names>PT</given-names></string-name>, <string-name><surname>Eastham</surname><given-names>JA</given-names></string-name>. <article-title>Radical prostatectomy: long‐term cancer control and recovery of sexual and urinary function ("trifecta")</article-title>. <source xml:lang="en">Urology</source><year>2005</year>; <volume>66</volume>(<issue>5 Suppl</issue>): <fpage>83</fpage>–<lpage>94</lpage>
<pub-id pub-id-type="pmid">16194712</pub-id></mixed-citation>
              </ref>
              <ref id="bju15238-bib-0004">
                <label>4</label>
                <mixed-citation publication-type="journal" id="bju15238-cit-0004"><string-name><surname>Johansson</surname><given-names>E</given-names></string-name>, <string-name><surname>Steineck</surname><given-names>G</given-names></string-name>, <string-name><surname>Holmberg</surname><given-names>L</given-names></string-name><bold>et al.</bold><article-title>Long‐term quality‐of‐life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group‐4 randomised trial</article-title>. <source xml:lang="en">Lancet Oncol</source><year>2011</year>; <volume>12</volume>: <fpage>891</fpage>–<lpage>9</lpage>
<pub-id pub-id-type="pmid">21821474</pub-id></mixed-citation>
              </ref>
              <ref id="bju15238-bib-0005">
                <label>5</label>
                <mixed-citation publication-type="journal" id="bju15238-cit-0005"><string-name><surname>Wallerstedt</surname><given-names>A</given-names></string-name>, <string-name><surname>Nyberg</surname><given-names>T</given-names></string-name>, <string-name><surname>Carlsson</surname><given-names>S</given-names></string-name><bold>et al.</bold><article-title>Quality of life after open radical prostatectomy compared with robot‐assisted radical prostatectomy</article-title>. <source xml:lang="en">Eur Urol Focus</source><year>2019</year>; <volume>5</volume>: <fpage>389</fpage>–<lpage>98</lpage>
<pub-id pub-id-type="pmid">29366855</pub-id></mixed-citation>
              </ref>
              <ref id="bju15238-bib-0006">
                <label>6</label>
                <mixed-citation publication-type="journal" id="bju15238-cit-0006"><string-name><surname>Haglind</surname><given-names>E</given-names></string-name>, <string-name><surname>Carlsson</surname><given-names>S</given-names></string-name>, <string-name><surname>Stranne</surname><given-names>J</given-names></string-name><bold>et al.</bold><article-title>Urinary incontinence and erectile dysfunction after robotic versus open radical prostatectomy: a prospective, controlled nonrandomised trial</article-title>. <source xml:lang="en">Eur Urol</source><year>2015</year>; <volume>68</volume>: <fpage>216</fpage>–<lpage>25</lpage>
<pub-id pub-id-type="pmid">25770484</pub-id></mixed-citation>
              </ref>
              <ref id="bju15238-bib-0007">
                <label>7</label>
                <mixed-citation publication-type="journal" id="bju15238-cit-0007"><string-name><surname>Hu</surname><given-names>JC</given-names></string-name>, <string-name><surname>Gu</surname><given-names>X</given-names></string-name>, <string-name><surname>Lipsitz</surname><given-names>SR</given-names></string-name><bold>et al.</bold><article-title>Comparative effectiveness of minimally invasive vs open radical prostatectomy</article-title>. <source xml:lang="en">JAMA</source><year>2009</year>; <volume>302</volume>: <fpage>1557</fpage>–<lpage>64</lpage>
<pub-id pub-id-type="pmid">19826025</pub-id></mixed-citation>
              </ref>
              <ref id="bju15238-bib-0008">
                <label>8</label>
                <mixed-citation publication-type="journal" id="bju15238-cit-0008"><string-name><surname>Barry</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Gallagher</surname><given-names>PM</given-names></string-name>, <string-name><surname>Skinner</surname><given-names>JS</given-names></string-name>, <string-name><surname>Fowler</surname><given-names>FJ</given-names><suffix>Jr</suffix></string-name>. <article-title>Adverse effects of robotic‐assisted laparoscopic versus open retropubic radical prostatectomy among a nationwide random sample of medicare‐age men</article-title>. <source xml:lang="en">J Clin Oncol</source><year>2012</year>; <volume>30</volume>: <fpage>513</fpage>–<lpage>8</lpage>
<pub-id pub-id-type="pmid">22215756</pub-id></mixed-citation>
              </ref>
              <ref id="bju15238-bib-0009">
                <label>9</label>
                <mixed-citation publication-type="journal" id="bju15238-cit-0009"><string-name><surname>Coughlin</surname><given-names>GD</given-names></string-name>, <string-name><surname>Yaxley</surname><given-names>JW</given-names></string-name>, <string-name><surname>Chambers</surname><given-names>SK</given-names></string-name><bold>et al.</bold><article-title>Robot‐assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: 24‐month outcomes from a randomised controlled study</article-title>. <source xml:lang="en">Lancet Oncol</source><year>2018</year>; <volume>19</volume>: <fpage>1051</fpage>–<lpage>60</lpage>
<pub-id pub-id-type="pmid">30017351</pub-id></mixed-citation>
              </ref>
              <ref id="bju15238-bib-0010">
                <label>10</label>
                <mixed-citation publication-type="journal" id="bju15238-cit-0010"><string-name><surname>Nossiter</surname><given-names>J</given-names></string-name>, <string-name><surname>Sujenthiran</surname><given-names>A</given-names></string-name>, <string-name><surname>Charman</surname><given-names>SC</given-names></string-name><bold>et al.</bold><article-title>Robot‐assisted radical prostatectomy vs laparoscopic and open retropubic radical prostatectomy: functional outcomes 18 months after diagnosis from a national cohort study in England</article-title>. <source xml:lang="en">Br J Cancer</source><year>2018</year>; <volume>118</volume>: <fpage>489</fpage>–<lpage>94</lpage>
<pub-id pub-id-type="pmid">29348490</pub-id></mixed-citation>
              </ref>
              <ref id="bju15238-bib-0011">
                <label>11</label>
                <mixed-citation publication-type="journal" id="bju15238-cit-0011"><string-name><surname>Ritch</surname><given-names>CR</given-names></string-name>, <string-name><surname>You</surname><given-names>C</given-names></string-name>, <string-name><surname>May</surname><given-names>AT</given-names></string-name><bold>et al.</bold><article-title>Biochemical recurrence‐free survival after robotic‐assisted laparoscopic vs open radical prostatectomy for intermediate‐ and high‐risk prostate cancer</article-title>. <source xml:lang="en">Urology</source><year>2014</year>; <volume>83</volume>: <fpage>1309</fpage>–<lpage>15</lpage>
<pub-id pub-id-type="pmid">24746665</pub-id></mixed-citation>
              </ref>
              <ref id="bju15238-bib-0012">
                <label>12</label>
                <mixed-citation publication-type="journal" id="bju15238-cit-0012"><string-name><surname>Herlemann</surname><given-names>A</given-names></string-name>, <string-name><surname>Cowan</surname><given-names>JE</given-names></string-name>, <string-name><surname>Carroll</surname><given-names>PR</given-names></string-name>, <string-name><surname>Cooperberg</surname><given-names>MR</given-names></string-name>. <article-title>Community‐based outcomes of open versus robot‐assisted radical prostatectomy</article-title>. <source xml:lang="en">Eur Urol.</source><year>2018</year>; <volume>73</volume>: <fpage>215</fpage>–<lpage>23</lpage>
<pub-id pub-id-type="pmid">28499617</pub-id></mixed-citation>
              </ref>
              <ref id="bju15238-bib-0013">
                <label>13</label>
                <mixed-citation publication-type="journal" id="bju15238-cit-0013"><string-name><surname>Alemozaffar</surname><given-names>M</given-names></string-name>, <string-name><surname>Sanda</surname><given-names>M</given-names></string-name>, <string-name><surname>Yecies</surname><given-names>D</given-names></string-name>, <string-name><surname>Mucci</surname><given-names>LA</given-names></string-name>, <string-name><surname>Stampfer</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Kenfield</surname><given-names>SA</given-names></string-name>. <article-title>Benchmarks for operative outcomes of robotic and open radical prostatectomy: results from the Health Professionals Follow‐up Study</article-title>. <source xml:lang="en">Eur Urol</source><year>2015</year>; <volume>67</volume>: <fpage>432</fpage>–<lpage>8</lpage>
<pub-id pub-id-type="pmid">24582327</pub-id></mixed-citation>
              </ref>
              <ref id="bju15238-bib-0014">
                <label>14</label>
                <mixed-citation publication-type="journal" id="bju15238-cit-0014"><string-name><surname>Tang</surname><given-names>K</given-names></string-name>, <string-name><surname>Jiang</surname><given-names>K</given-names></string-name>, <string-name><surname>Chen</surname><given-names>H</given-names></string-name>, <string-name><surname>Chen</surname><given-names>Z</given-names></string-name>, <string-name><surname>Xu</surname><given-names>H</given-names></string-name>, <string-name><surname>Ye</surname><given-names>Z</given-names></string-name>. <article-title>Robotic vs. Retropubic radical prostatectomy in prostate cancer: a systematic review and an meta‐analysis update</article-title>. <source xml:lang="en">Oncotarget</source><year>2017</year>; <volume>8</volume>: <fpage>32237</fpage>–<lpage>57</lpage>
<pub-id pub-id-type="pmid">27852051</pub-id></mixed-citation>
              </ref>
              <ref id="bju15238-bib-0015">
                <label>15</label>
                <mixed-citation publication-type="journal" id="bju15238-cit-0015"><string-name><surname>Vickers</surname><given-names>A</given-names></string-name>, <string-name><surname>Savage</surname><given-names>C</given-names></string-name>, <string-name><surname>Bianco</surname><given-names>F</given-names></string-name><bold>et al.</bold><article-title>Cancer control and functional outcomes after radical prostatectomy as markers of surgical quality: analysis of heterogeneity between surgeons at a single cancer center</article-title>. <source xml:lang="en">Eur Urol</source><year>2011</year>; <volume>59</volume>: <fpage>317</fpage>–<lpage>22</lpage>
<pub-id pub-id-type="pmid">21095055</pub-id></mixed-citation>
              </ref>
              <ref id="bju15238-bib-0016">
                <label>16</label>
                <mixed-citation publication-type="journal" id="bju15238-cit-0016"><string-name><surname>Carlsson</surname><given-names>S</given-names></string-name>, <string-name><surname>Berglund</surname><given-names>A</given-names></string-name>, <string-name><surname>Sjoberg</surname><given-names>D</given-names></string-name><bold>et al.</bold><article-title>Effects of surgeon variability on oncologic and functional outcomes in a population‐based setting</article-title>. <source xml:lang="en">BMC Urol</source><year>2014</year>; <volume>14</volume>: <fpage>25</fpage><pub-id pub-id-type="pmid">24602348</pub-id></mixed-citation>
              </ref>
              <ref id="bju15238-bib-0017">
                <label>17</label>
                <mixed-citation publication-type="journal" id="bju15238-cit-0017"><string-name><surname>Bianco</surname><given-names>FJ</given-names><suffix>Jr</suffix></string-name>, <string-name><surname>Vickers</surname><given-names>AJ</given-names></string-name>, <string-name><surname>Cronin</surname><given-names>AM</given-names></string-name><bold>et al.</bold><article-title>Variations among experienced surgeons in cancer control after open radical prostatectomy</article-title>. <source xml:lang="en">J Urol</source><year>2010</year>; <volume>183</volume>: <fpage>977</fpage>–<lpage>82</lpage>
<pub-id pub-id-type="pmid">20083278</pub-id></mixed-citation>
              </ref>
              <ref id="bju15238-bib-0018">
                <label>18</label>
                <mixed-citation publication-type="journal" id="bju15238-cit-0018"><string-name><surname>Nyberg</surname><given-names>M</given-names></string-name>, <string-name><surname>Hugosson</surname><given-names>J</given-names></string-name>, <string-name><surname>Wiklund</surname><given-names>P</given-names></string-name><bold>et al.</bold><article-title>Functional and oncologic outcomes between open and robotic radical prostatectomy at 24‐month follow‐up in the Swedish LAPPRO trial</article-title>. <source xml:lang="en">Eur Urol Oncol</source><year>2018</year>; <volume>1</volume>: <fpage>353</fpage>–<lpage>60</lpage>
<pub-id pub-id-type="pmid">31158073</pub-id></mixed-citation>
              </ref>
              <ref id="bju15238-bib-0019">
                <label>19</label>
                <mixed-citation publication-type="journal" id="bju15238-cit-0019"><string-name><surname>Thorsteinsdottir</surname><given-names>T</given-names></string-name>, <string-name><surname>Stranne</surname><given-names>J</given-names></string-name>, <string-name><surname>Carlsson</surname><given-names>S</given-names></string-name><bold>et al.</bold><article-title>LAPPRO: a prospective multicentre comparative study of robot‐assisted laparoscopic and retropubic radical prostatectomy for prostate cancer</article-title>. <source xml:lang="en">Scand J Urol Nephrol</source><year>2011</year>; <volume>45</volume>: <fpage>102</fpage>–<lpage>12</lpage>
<pub-id pub-id-type="pmid">21114378</pub-id></mixed-citation>
              </ref>
              <ref id="bju15238-bib-0020">
                <label>20</label>
                <mixed-citation publication-type="journal" id="bju15238-cit-0020"><string-name><surname>Bates</surname><given-names>D</given-names></string-name>, <string-name><surname>Mächler</surname><given-names>M</given-names></string-name>, <string-name><surname>Bolker</surname><given-names>B</given-names></string-name>, <string-name><surname>Walker</surname><given-names>S</given-names></string-name>. <article-title>Fitting linear mixed‐effects models using lme4</article-title>. <source xml:lang="en">J Stat Softw</source><year>2015</year>; <volume>67</volume>: <fpage>48</fpage></mixed-citation>
              </ref>
              <ref id="bju15238-bib-0021">
                <label>21</label>
                <mixed-citation publication-type="journal" id="bju15238-cit-0021"><string-name><surname>Vickers</surname><given-names>AJ</given-names></string-name>, <string-name><surname>Bianco</surname><given-names>FJ</given-names></string-name>, <string-name><surname>Serio</surname><given-names>AM</given-names></string-name><bold>et al.</bold><article-title>The surgical learning curve for prostate cancer control after radical prostatectomy</article-title>. <source xml:lang="en">J Natl Cancer Inst</source><year>2007</year>; <volume>99</volume>: <fpage>1171</fpage>–<lpage>7</lpage>
<pub-id pub-id-type="pmid">17652279</pub-id></mixed-citation>
              </ref>
              <ref id="bju15238-bib-0022">
                <label>22</label>
                <mixed-citation publication-type="journal" id="bju15238-cit-0022"><string-name><surname>Eastham</surname><given-names>JA</given-names></string-name>. <article-title>Do high‐volume hospitals and surgeons provide better care in urologic oncology?</article-title><source xml:lang="en">Urol Oncol</source><year>2009</year>; <volume>27</volume>: <fpage>417</fpage>–<lpage>21</lpage>
<pub-id pub-id-type="pmid">19573772</pub-id></mixed-citation>
              </ref>
              <ref id="bju15238-bib-0023">
                <label>23</label>
                <mixed-citation publication-type="journal" id="bju15238-cit-0023"><string-name><surname>Begg</surname><given-names>CB</given-names></string-name>, <string-name><surname>Riedel</surname><given-names>ER</given-names></string-name>, <string-name><surname>Bach</surname><given-names>PB</given-names></string-name><bold>et al.</bold><article-title>Variations in morbidity after radical prostatectomy</article-title>. <source xml:lang="en">N Engl J Med</source><year>2002</year>; <volume>346</volume>: <fpage>1138</fpage>–<lpage>44</lpage>
<pub-id pub-id-type="pmid">11948274</pub-id></mixed-citation>
              </ref>
              <ref id="bju15238-bib-0024">
                <label>24</label>
                <mixed-citation publication-type="journal" id="bju15238-cit-0024"><string-name><surname>Huynh</surname><given-names>LM</given-names></string-name>, <string-name><surname>Skarecky</surname><given-names>D</given-names></string-name>, <string-name><surname>Porter</surname><given-names>J</given-names></string-name><bold>et al.</bold><article-title>A randomized control trial of anti‐inflammatory regional hypothermia on urinary continence during robot‐assisted radical prostatectomy</article-title>. <source xml:lang="en">Sci Rep</source><year>2018</year>; <volume>8</volume>: <fpage>16352</fpage><pub-id pub-id-type="pmid">30397236</pub-id></mixed-citation>
              </ref>
              <ref id="bju15238-bib-0025">
                <label>25</label>
                <mixed-citation publication-type="journal" id="bju15238-cit-0025"><string-name><surname>Trinh</surname><given-names>QD</given-names></string-name>, <string-name><surname>Bjartell</surname><given-names>A</given-names></string-name>, <string-name><surname>Freedland</surname><given-names>SJ</given-names></string-name><bold>et al.</bold><article-title>A systematic review of the volume‐outcome relationship for radical prostatectomy</article-title>. <source xml:lang="en">Eur Urol</source><year>2013</year>; <volume>64</volume>: <fpage>786</fpage>–<lpage>98</lpage>
<pub-id pub-id-type="pmid">23664423</pub-id></mixed-citation>
              </ref>
              <ref id="bju15238-bib-0026">
                <label>26</label>
                <mixed-citation publication-type="journal" id="bju15238-cit-0026"><string-name><surname>Vickers</surname><given-names>AJ</given-names></string-name>, <string-name><surname>Savage</surname><given-names>CJ</given-names></string-name>, <string-name><surname>Hruza</surname><given-names>M</given-names></string-name><bold>et al.</bold><article-title>The surgical learning curve for laparoscopic radical prostatectomy: a retrospective cohort study</article-title>. <source xml:lang="en">Lancet Oncol</source><year>2009</year>; <volume>10</volume>: <fpage>475</fpage>–<lpage>80</lpage>
<pub-id pub-id-type="pmid">19342300</pub-id></mixed-citation>
              </ref>
              <ref id="bju15238-bib-0027">
                <label>27</label>
                <mixed-citation publication-type="journal" id="bju15238-cit-0027"><string-name><surname>Thompson</surname><given-names>JE</given-names></string-name>, <string-name><surname>Egger</surname><given-names>S</given-names></string-name>, <string-name><surname>Böhm</surname><given-names>M</given-names></string-name><bold>et al.</bold><article-title>Superior biochemical recurrence and long‐term quality‐of‐life outcomes are achievable with robotic radical prostatectomy after a long learning curve‐updated analysis of a prospective single‐surgeon cohort of 2206 consecutive cases</article-title>. <source xml:lang="en">Eur Urol</source><year>2018</year>; <volume>73</volume>: <fpage>664</fpage>–<lpage>71</lpage>
<pub-id pub-id-type="pmid">29273404</pub-id></mixed-citation>
              </ref>
              <ref id="bju15238-bib-0028">
                <label>28</label>
                <mixed-citation publication-type="journal" id="bju15238-cit-0028"><string-name><surname>Bravi</surname><given-names>CA</given-names></string-name>, <string-name><surname>Tin</surname><given-names>A</given-names></string-name>, <string-name><surname>Vertosick</surname><given-names>E</given-names></string-name><bold>et al.</bold><article-title>The impact of experience on the risk of surgical margins and biochemical recurrence after robot‐assisted radical prostatectomy: a learning curve study</article-title>. <source xml:lang="en">J Urol</source><year>2019</year>; <volume>202</volume>: <fpage>108</fpage>–<lpage>13</lpage>
<pub-id pub-id-type="pmid">30747873</pub-id></mixed-citation>
              </ref>
              <ref id="bju15238-bib-0029">
                <label>29</label>
                <mixed-citation publication-type="journal" id="bju15238-cit-0029"><string-name><surname>Sivaraman</surname><given-names>A</given-names></string-name>, <string-name><surname>Sanchez‐Salas</surname><given-names>R</given-names></string-name>, <string-name><surname>Prapotnich</surname><given-names>D</given-names></string-name><bold>et al.</bold><article-title>Learning curve of minimally invasive radical prostatectomy: comprehensive evaluation and cumulative summation analysis of oncological outcomes</article-title>. <source xml:lang="en">Urol Oncol</source><year>2017</year>; <volume>35</volume>: <fpage>149</fpage>.e1–e6</mixed-citation>
              </ref>
              <ref id="bju15238-bib-0030">
                <label>30</label>
                <mixed-citation publication-type="journal" id="bju15238-cit-0030"><string-name><surname>Sooriakumaran</surname><given-names>P</given-names></string-name>, <string-name><surname>Pini</surname><given-names>G</given-names></string-name>, <string-name><surname>Nyberg</surname><given-names>T</given-names></string-name><bold>et al.</bold><article-title>Erectile function and oncologic outcomes following open retropubic and robot‐assisted radical prostatectomy: results from the laparoscopic prostatectomy robot open trial</article-title>. <source xml:lang="en">Eur Urol</source><year>2018</year>; <volume>73</volume>: <fpage>618</fpage>–<lpage>627</lpage>
<pub-id pub-id-type="pmid">28882327</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
